These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35777657)

  • 21. Dynamic changes of viral load and the duration of viral shedding in patients with hand, foot and mouth disease: a protocol for longitudinal study.
    Duan X; Zhang C; Chen Z; Liao J; Zeng Y; Huang W; Ren X; Tang X; Peng H; Zhang D; Wang X; Yuan P; Long L
    BMC Infect Dis; 2022 Feb; 22(1):162. PubMed ID: 35184744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic Interaction of Enterovirus 71 and Dendritic Cells in Infected Neonatal Rhesus Macaques.
    Zhao T; Zhang Z; Zhang Y; Feng M; Fan S; Wang L; Liu L; Wang X; Wang Q; Zhang X; Wang J; Liao Y; He Z; Lu S; Yang H; Li Q
    Front Cell Infect Microbiol; 2017; 7():171. PubMed ID: 28540257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease.
    Anasir MI; Poh CL
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence, circulation, and spatiotemporal phylogenetic analysis of coxsackievirus a6- and coxsackievirus a10-associated hand, foot, and mouth disease infections from 2008 to 2012 in Shenzhen, China.
    He YQ; Chen L; Xu WB; Yang H; Wang HZ; Zong WP; Xian HX; Chen HL; Yao XJ; Hu ZL; Luo M; Zhang HL; Ma HW; Cheng JQ; Feng QJ; Zhao DJ
    J Clin Microbiol; 2013 Nov; 51(11):3560-6. PubMed ID: 23966496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic characterization of VP1 of coxsackieviruses A2, A4, and A10 associated with hand, foot, and mouth disease in Vietnam in 2012-2017: endemic circulation and emergence of new HFMD-causing lineages.
    Hoa-Tran TN; Nguyen AT; Dao ATH; Kataoka C; Ta HTT; Nguyen HTV; Takemura T; Nguyen TTT; Vu HM; Nguyen TTH; Shimizu H
    Arch Virol; 2020 Apr; 165(4):823-834. PubMed ID: 32008121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease.
    Fang CY; Liu CC
    Expert Rev Vaccines; 2018 Sep; 17(9):819-831. PubMed ID: 30095317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.
    Zhang Z; Dong Z; Li J; Carr MJ; Zhuang D; Wang J; Zhang Y; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden.
    Ji H; Fan H; Lu PX; Zhang XF; Ai J; Shi C; Huo X; Bao CJ; Shan J; Jin Y
    BMC Infect Dis; 2019 Jan; 19(1):79. PubMed ID: 30669973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of integrated protective immunity induced in rhesus macaques by the intradermal administration of a bivalent EV71-CA16 inactivated vaccine.
    Fan S; Liao Y; Jiang G; Jiang L; Wang L; Xu X; Feng M; Yang E; Zhang Y; Cui W; Li Q
    Vaccine; 2020 Feb; 38(8):2034-2044. PubMed ID: 31982260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical analysis of 555 outpatients with hand, foot and mouth diseases caused by different enteroviruses].
    Cui P; Li Y; Zhou CC; Zhou YH; Song CL; Qiu Q; Wang F; Guo C; Han SJ; Liang L; Yuan Y; Zeng MY; Yue J; Long L; Qin XH; Li Z; Chen XL; Zou YP; Cheng YB; Yu HJ
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):445-451. PubMed ID: 31216802
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety and immunogenicity of an experimental live combination vaccine against enterovirus 71 and coxsackievirus A16 in rhesus monkeys.
    Yang T; Xie T; Song X; Shen D; Li H; Yue L; Jiang Q; Zhu F; Meng H; Long R; Yang R; Luo F; Xie Z
    Hum Vaccin Immunother; 2020 Jul; 16(7):1586-1594. PubMed ID: 32159429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Etiology study on severe cases caused by hand-foot-mouth disease in children from Henan province, 2014].
    Li X; Li Y; Zhang B; Sui M; Pan J; Chen Z; Cheng N; Du Y; Wei H; Xu B; Huang X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Apr; 37(4):568-71. PubMed ID: 27087228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
    Mao Q; Wang Y; Bian L; Xu M; Liang Z
    Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro antiviral activity of medicinal mushroom Ganoderma neo-japonicum Imazeki against enteroviruses that caused hand, foot and mouth disease.
    Ang WX; Sarasvathy S; Kuppusamy UR; Sabaratnam V; Tan SH; Wong KT; Perera D; Ong KC
    Trop Biomed; 2021 Sep; 38(3):239-247. PubMed ID: 34362866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA expression profile of human umbilical vein endothelial cells in response to coxsackievirus A10 infection reveals a potential role of miR-143-3p in maintaining the integrity of the blood-brain barrier.
    Hu Y; Cui F; Wang S; Liu C; Zhang S; Wang R; Song J; Zhang Y
    Front Cell Infect Microbiol; 2023; 13():1217984. PubMed ID: 37577373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study.
    Mirand A; Henquell C; Archimbaud C; Ughetto S; Antona D; Bailly JL; Peigue-Lafeuille H
    Clin Microbiol Infect; 2012 May; 18(5):E110-8. PubMed ID: 22404077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemical and etiological study on hand, foot and mouth disease following EV-A71 vaccination in Xiangyang, China.
    Meng XD; Tong Y; Wei ZN; Wang L; Mai JY; Wu Y; Luo ZY; Li S; Li M; Wang S; Wei S; Gong W; Zhang W; Hu X; Huang J; Shi J; Yang G; Meng S; Wang Z; Guan X; Shen S
    Sci Rep; 2020 Dec; 10(1):20909. PubMed ID: 33262488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and epidemiological characteristics of Coxsackievirus A6- and Enterovirus 71-associated clinical stage 2 and 3 severe hand, foot, and mouth disease in Guangxi, Southern China, 2017.
    Ju Y; Tan Z; Huang H; Chen M; Tan Y; Zhang C; Wang J; Wang H; Chen M
    J Infect; 2020 Jan; 80(1):121-142. PubMed ID: 31629866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is a multivalent hand, foot, and mouth disease vaccine feasible?
    Klein M; Chong P
    Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fourteen types of co-circulating recombinant enterovirus were associated with hand, foot, and mouth disease in children from Wenzhou, China.
    Guo WP; Lin XD; Chen YP; Liu Q; Wang W; Wang CQ; Li MH; Sun XY; Shi M; Holmes EC; Zhang YZ
    J Clin Virol; 2015 Sep; 70():29-38. PubMed ID: 26305816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.